PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25626N0370LAB TESTS for POST transplant CARE — Caredx, Inc

Caredx, Inc holds $10.5M across 27 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25625D0053. Recompete timing centers on the Mar 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

256-Network Contract Office 16 (36C256)

Awarding office

Caredx, Inc

Recipient

Mar 31, 2027

PoP end

$771K

Obligated

$771K

Potential

621511

NAICS

Q301

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Caredx, Inc — $90

Contract facts

Federal

Contract number36C25626N0370

Also listed as36C256-26-N-0370

Also listed as36C25625D0053-36C25626N0370

Agency256-Network Contract Office 16 (36C256)

Awarding office256-Network Contract Office 16 (36C256)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentCaredx, Inc

CAGE53C84

UEIY371A27ZEUM4

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301

Parent IDIQ / IDV36C25625D0053

Place of performanceHOUSTON TX

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startApr 1, 2026

PoP end (current)Mar 31, 2027

Obligated$771K

Current value$771K

Potential value$771K

LAB TESTS FOR POST TRANSPLANT CARE. is a federal award for 256-Network Contract Office 16 (36C256) held by Caredx, Inc. Estimated value $771K ($771K obligated). Current period of performance ends Mar 31, 2027. Place of performance: HOUSTON TX.

Recompete timing

Public

● Expiring in 222 days

Current PoP ends Mar 31, 2027 (222 days remaining). Agencies typically plan 12–18 months ahead — at 7.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Caredx, Inc — $10.5M obligated across 27 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$10.5M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

36C24925N0545

GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

$492K

Sep 22, 2026

36C25221N0645

ALLOSURE KIDNEY TESTING

$486K

Sep 29, 2026

36C25226N0079

TRANSPLANT TESTING KITS

$1.6M

Jan 31, 2027

36C26122C0017

ALLOMAP AND ALLOSURE POST HEART TRANSPLANT REJECTION SURVEILLANCE TESTS SERVICES

$1.3M

Feb 28, 2027

36C25922C0115

ALLOMAP GENE TESTING

$117K

Jul 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25626N0370?

36C25626N0370 (LAB TESTS for POST transplant CARE) is a 256-Network Contract Office 16 (36C256) award with a potential value of $771K, currently held by Caredx, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C256-26-N-0370?

36C256-26-N-0370 is the dashed form of PIID 36C25626N0370 (LAB TESTS for POST transplant CARE), held by Caredx, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25626N0370?

256-Network Contract Office 16 (36C256) awarded 36C25626N0370 to Caredx, Inc (potential $771K).

Who is the incumbent on 36C25626N0370?

Caredx, Inc is the incumbent with $10.5M across 27 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2027.

When does Caredx, Inc’s 36C25626N0370 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Feb 6, 2026